model: gpt-4-1106-preview
prompt: Write a paragraph of text in the style of a biomedical research article. Include the following protein complex name: interleukin-20 receptor. Use this name exactly as provided, avoiding any synonyms, aliases, abbreviated or expanded forms. Also avoid including any other names referring to a gene, protein, protein complex, protein part or component, or any other molecular entity containing amino acid residues. The text can include mentions of other biomedical entity types, such as chemical, organism, and disease names.
output: Recent advances in inflammatory signaling have elucidated the critical role of the interleukin-20 receptor in the pathogenesis of psoriasis. Activation of this receptor complex by its specific ligands induces a cascade of intracellular events, ultimately leading to the transcription of target genes that govern the proliferation and differentiation of keratinocytes. These findings stem from a series of in vitro assays using cultured human epidermal tissues, which mimic the immunological milieu of psoriatic lesions, and in vivo studies conducted on murine models. Notably, the administration of monoclonal antibodies targeting the interleukin-20 receptor has demonstrated a marked reduction in the clinical severity of psoriasis, characterized by a decrease in erythema, plaque formation, and skin scaling. Concurrently, cytokine profiling has shown a corresponding decline in inflammatory mediators, revealing the therapeutic potential of this intervention. The specific inhibition of the interleukin-20 receptor thus represents a promising avenue for the development of novel targeted treatments for psoriasis, with implications extending to other diseases characterized by aberrant skin proliferation and inflammation.
